Investor Cooperatieve Gilde Healthcare IV U.A.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Cooperatieve Gilde Healthcare IV U.A. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-02-06 13D/A CVRX / CVRx, Inc. 1,368,206 1,231,490
2024-01-19 13D/A CVRX / CVRx, Inc. 1,598,763 1,368,206
2023-12-29 13D/A CVRX / CVRx, Inc. 1,831,490 1,598,763
2022-06-06 13G/A AXNX / Axonics, Inc. 1,376,733 0
2021-09-08 13D/A NARI / Inari Medical, Inc. 3,248,757 2,400,612
2021-08-27 13D/A NARI / Inari Medical, Inc. 3,896,433 3,248,757
2021-07-12 13D CVRX / CVRx, Inc. 1,831,490
2021-04-27 13D/A NARI / Inari Medical, Inc. 4,491,679 3,896,433
2021-03-31 13D LVTX / LAVA Therapeutics N.V. 5,421,170
2021-03-16 13D/A NARI / Inari Medical, Inc. 6,246,515 4,491,679
2021-02-08 13G/A AXNX / Axonics, Inc. 3,133,332 1,376,733
2020-12-23 13D/A NARI / Inari Medical, Inc. 7,404,008 6,246,515
2020-12-04 13D/A NARI / Inari Medical, Inc. 7,941,679 7,404,008
2020-06-05 13D NARI / Inari Medical, Inc. 7,941,679
2019-12-10 13G AXNX / Axonics, Inc. 3,133,332 3,133,332
2019-11-27 13D/A AXNX / Axonics, Inc. 3,133,332 3,133,332
2019-01-04 13D AXNX / Axonics, Inc. 3,133,332